Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pharma-Bio Serv (PBSV) Assets Average (2016 - 2026)

Pharma-Bio Serv filings provide 14 years of Assets Average readings, the most recent being $13.6 million for Q1 2026.

  • On a quarterly basis, Assets Average fell 15.97% to $13.6 million in Q1 2026 year-over-year; TTM through Jan 2026 was $13.6 million, a 15.97% decrease, with the full-year FY2025 number at $15.0 million, down 17.27% from a year prior.
  • Assets Average hit $13.6 million in Q1 2026 for Pharma-Bio Serv, roughly flat from $13.6 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $23.0 million in Q1 2022 to a low of $13.6 million in Q1 2026.
  • Median Assets Average over the past 5 years was $19.6 million (2024), compared with a mean of $18.3 million.
  • Biggest five-year swings in Assets Average: decreased 28.33% in 2022 and later grew 0.67% in 2023.
  • Pharma-Bio Serv's Assets Average stood at $20.5 million in 2022, then fell by 1.91% to $20.1 million in 2023, then dropped by 18.88% to $16.3 million in 2024, then dropped by 16.47% to $13.6 million in 2025, then fell by 0.14% to $13.6 million in 2026.
  • The last three reported values for Assets Average were $13.6 million (Q1 2026), $13.6 million (Q4 2025), and $13.7 million (Q3 2025) per Business Quant data.